Silence Therapeutics

Silence Therapeutics Develops New Generation of Drugs by Leveraging the Natural Mechanism of RNA Interference (RNAi) Within Human Cells. Silence Therapeutics' Proprietary Technology Can Selectively Inhibit Any Gene in the Genome, Particularly Suppressing the Production of Pathogenic Proteins. Using an Activated Delivery System, Silence Achieves a Higher Level of Specificity by Fully Delivering Therapeutic RNA Molecules Into Target Cells. Silence's Patented RNA Chemistry and Delivery System Are Designed to Enhance Molecular Stability and Improve Effective Transmission to Target Cells, Offering a Powerful Modular Technology Highly Suitable for Addressing Life-Threatening Diseases.